Sukumar Nagendran - Jun 12, 2025 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role: Director
Signature: /s/ by David Tyronne Howton as attorney-in-fact for Sukumar Nagendran
Stock symbol: SLDB
Transactions as of: Jun 12, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/13/2025, 04:25 PM
Previous filing: Jan 3, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Nagendran Sukumar	Director	C/O SOLID BIOSCIENCES INC., 500 RUTHERFORD AVENUE, THIRD FLOOR, CHARLESTOWN	/s/ by David Tyronne Howton as attorney-in-fact for Sukumar Nagendran	2025-06-13	0001665124

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SLDB	Director Stock Option (Right to Buy)	Award	$0	+77.5K		$0.00	77.5K	Jun 12, 2025	Common Stock	77.5K	$4.58	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on June 12, 2025 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.